Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$20.14 -0.30 (-1.47%)
As of: Oct 21, 2026 · 3:19 PM EDT

Acadia Pharmaceuticals (ACAD) Assets (2010 - 2026)

Updated

Acadia Pharmaceuticals (ACAD) posted Assets of $1.74 billion for Q2 2026, up 42.2% from $1.23 billion a year earlier and up 8.6% from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Assets (2010 - 2026) Analysis & Trends

At the end of FY2025, Acadia Pharmaceuticals' Assets came in at $1.56 billion, up 31.7% from FY2024.

  • Annual Assets has increased for three consecutive years, with a five-year compound annual growth rate of 14.9% (FY2020 to FY2025).
  • In prior years, Acadia Pharmaceuticals' Assets was $1.19 billion in FY2024 (+58.6%), $748.96 million in FY2023 (+27.4%), $587.81 million in FY2022 (-16.0%) and $700.12 million in FY2021 (-10.5%).
  • The Q2 2026 figure stands as the highest quarterly Assets in data going back to Q4 2010.
  • On a year-over-year basis, Assets has increased in each of the last 14 quarters, with growth averaging 41.4% over the last eight quarters.
  • The strongest year-over-year quarter for Assets in the past five years was Q4 2024, with growth of 58.6%; the weakest was Q1 2022, with a decline of 17.3%.
  • According to Business Quant data, Assets for the three prior quarters was $1.61 billion (Q1 2026), $1.56 billion (Q4 2025) and $1.33 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,137.48 Bn 1,106.07 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 618.81 Bn 537.34 Bn 17.26 Bn 201.06 Bn
3 AbbVie 502.02 Bn 475.14 Bn 12.70 Bn 135.12 Bn
4 Merck 368.25 Bn 322.63 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 297.87 Bn 261.86 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 260.90 Bn 234.58 Bn 12.86 Bn 115.83 Bn
7 Amgen 236.67 Bn 192.07 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 191.16 Bn 165.36 Bn 6.22 Bn 49.36 Bn
9 Pfizer 169.69 Bn 116.34 Bn 10.94 Bn 201.13 Bn
10 Acadia Pharmaceuticals 3.46 Bn -15.98 Mn 279.64 Mn 1.74 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.74 Bn
Mar 31, 2026 1.61 Bn
Dec 31, 2025 1.56 Bn
Sep 30, 2025 1.33 Bn
Jun 30, 2025 1.23 Bn
Mar 31, 2025 1.13 Bn
Dec 31, 2024 1.19 Bn
Sep 30, 2024 976.87 Mn
Jun 30, 2024 914.10 Mn
Mar 31, 2024 855.10 Mn
Dec 31, 2023 748.96 Mn
Sep 30, 2023 632.54 Mn
Jun 30, 2023 642.77 Mn
Mar 31, 2023 655.31 Mn
Dec 31, 2022 587.81 Mn
Sep 30, 2022 602.49 Mn
Jun 30, 2022 612.77 Mn
Mar 31, 2022 624.25 Mn
Dec 31, 2021 700.12 Mn
Sep 30, 2021 717.67 Mn
API Access

Acadia Pharmaceuticals Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=ACAD&period=max&api_key=YOUR_API_KEY